Your browser is no longer supported. Please, upgrade your browser.
Settings
MRK Merck & Co., Inc. daily Stock Chart
MRK [NYSE]
Merck & Co., Inc.
IndexDJIA S&P500 P/E20.38 EPS (ttm)3.98 Insider Own0.10% Shs Outstand2.53B Perf Week0.97%
Market Cap201.32B Forward P/E13.23 EPS next Y6.13 Insider Trans-2.56% Shs Float2.52B Perf Month5.65%
Income10.20B PEG3.01 EPS next Q1.35 Inst Own77.80% Short Float0.58% Perf Quarter6.05%
Sales48.08B P/S4.19 EPS this Y58.90% Inst Trans0.33% Short Ratio1.51 Perf Half Y-4.77%
Book/sh10.35 P/B7.83 EPS next Y14.46% ROA12.10% Target Price93.00 Perf Year-4.38%
Cash/sh2.99 P/C27.09 EPS next 5Y6.78% ROE38.10% 52W Range65.25 - 92.64 Perf YTD-10.92%
Dividend2.44 P/FCF64.34 EPS past 5Y-1.10% ROI19.20% 52W High-12.54% Beta0.49
Dividend %3.01% Quick Ratio0.90 Sales past 5Y2.10% Gross Margin72.20% 52W Low24.17% ATR1.65
Employees71000 Current Ratio1.10 Sales Q/Q11.50% Oper. Margin25.50% RSI (14)54.71 Volatility1.86% 1.91%
OptionableYes Debt/Eq1.07 EPS Q/Q10.30% Profit Margin21.10% Rel Volume0.69 Prev Close81.05
ShortableYes LT Debt/Eq0.83 EarningsJul 31 BMO Payout58.30% Avg Volume9.69M Price81.02
Recom2.00 SMA202.08% SMA502.81% SMA200-1.09% Volume6,656,088 Change-0.04%
Aug-03-20Upgrade Goldman Neutral → Buy $91 → $105
Jun-12-20Downgrade Wolfe Research Outperform → Peer Perform
Feb-27-20Initiated Barclays Overweight $93
Jan-07-20Initiated RBC Capital Mkts Sector Perform $99
Oct-17-19Resumed BofA/Merrill Neutral $90
Aug-16-19Initiated SVB Leerink Outperform
Jul-03-19Initiated Mizuho Buy $97
May-28-19Initiated Goldman Neutral
May-13-19Upgrade Atlantic Equities Neutral → Overweight
Oct-16-18Reiterated Citigroup Buy $70 → $79
Oct-09-18Resumed Guggenheim Buy
Apr-23-18Upgrade Goldman Neutral → Buy
Apr-17-18Upgrade Morgan Stanley Equal-Weight → Overweight
Apr-05-18Upgrade Barclays Equal Weight → Overweight $62 → $64
Mar-12-18Upgrade Leerink Partners Mkt Perform → Outperform
Feb-14-18Reiterated Leerink Partners Mkt Perform $67 → $66
Feb-07-18Reiterated Morgan Stanley Equal-Weight $60 → $63
Jan-16-18Upgrade SunTrust Hold → Buy
Nov-28-17Resumed BofA/Merrill Buy $64
Nov-24-17Reiterated Deutsche Bank Hold $62 → $59
Aug-07-20 04:25PM  
12:19PM  
11:08AM  
09:11AM  
Aug-06-20 04:25PM  
01:42PM  
12:54PM  
12:31PM  
06:59AM  
Aug-05-20 04:25PM  
11:18AM  
07:00AM  
Aug-04-20 04:25PM  
08:06AM  
06:07AM  
05:00AM  
Aug-03-20 04:28PM  
04:25PM  
03:06PM  
02:24PM  
12:54PM  
12:22PM  
11:12AM  
11:03AM  
10:47AM  
09:45AM  
06:30AM  
Aug-02-20 04:31PM  
Aug-01-20 01:03AM  
Jul-31-20 06:33PM  
06:04PM  
04:31PM  
04:25PM  
01:05PM  
12:00PM  
11:56AM  
11:52AM  
11:47AM  
11:41AM  
10:36AM  
09:54AM  
09:10AM  
09:04AM  
08:45AM  
08:25AM  
07:41AM  
07:00AM  
07:00AM  
06:58AM  
06:55AM  
06:45AM  
Jul-30-20 04:25PM  
01:04PM  
12:58PM  
06:45AM  
03:33AM  
Jul-29-20 07:32AM  
06:45AM  
Jul-28-20 05:05PM  
04:36PM  
09:42AM  
Jul-27-20 06:11PM  
Jul-25-20 12:01PM  
Jul-24-20 04:57PM  
01:14PM  
12:30PM  
12:16PM  
10:46AM  
Jul-23-20 01:08PM  
11:39AM  
Jul-22-20 02:06PM  
Jul-21-20 04:48PM  
04:09PM  
02:50PM  
11:16AM  
09:34AM  
Jul-20-20 07:00AM  
Jul-19-20 11:09AM  
Jul-17-20 11:34AM  
11:12AM  
06:30AM  
Jul-16-20 07:30PM  
12:05PM  
11:29AM  
06:45AM  
Jul-15-20 04:38PM  
12:05PM  
09:48AM  
09:10AM  
09:00AM  
Jul-14-20 04:44PM  
09:45AM  
Jul-13-20 06:33PM  
Jul-10-20 10:21AM  
Jul-09-20 04:30PM  
02:10PM  
11:44AM  
08:53AM  
08:45AM  
08:40AM  
Merck & Co., Inc. provides healthcare solutions worldwide. The company offers therapeutic and preventive agents for cardiovascular, type 2 diabetes, chronic hepatitis C virus, HIV-1 infection, intra-abdominal, fungal infection, insomnia, and inflammatory diseases; neuromuscular blocking agents; cholesterol modifying medicines; and anti-bacterial and vaginal contraceptive products. It provides products to prevent chemotherapy-induced and post-operative nausea and vomiting; treat non-small-cell lung, ovarian and breast, esophageal, thyroid, cervical, and brain cancers; and prevent diseases caused by human papillomavirus, as well as vaccines for measles, mumps, rubella, varicella, shingles, rotavirus gastroenteritis, and pneumococcal diseases. In addition, the company offers drugs for hepatocellular and merkel cell carcinoma; antibiotic and anti-inflammatory drugs for infectious and respiratory diseases, fertility disorders, and pneumonia in cattle, bovine, and swine; vaccines for poultry; parasiticides for sea lice in salmon; and antibiotics and vaccines for fish. Further, it provides companion animal products; diabetes mellitus treatment and anthelmintic products for dogs and cats; products to treat fleas, ticks, mosquitoes, and sandflies; horse fertility management products for swine; and dog, cat, and horse vaccines. Additionally, the company offers services and solutions that focus on engagement, clinical, and health analytics. Merck & Co., Inc. has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Almac Discovery Ltd.; Skyhawk Therapeutics, Inc.; Ridgeback Biotherapeutics; Shanghai Junshi Biosciences Co., Ltd.; and FUJIFILM Corporation. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers; and physicians and physician distributors, veterinarians, and animal producers. The company was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Clyburn FrankEVP, Chief Commercial OfficerAug 05Option Exercise0.0018,876099,639Aug 06 04:53 PM
Clyburn FrankEVP, Chief Commercial OfficerAug 05Sale81.5518,8761,539,27480,763Aug 06 04:53 PM
Gerberding Julie L.EVP Strat Comm, GI Pub PolicyJul 17Option Exercise0.0018,111062,862Jul 20 04:53 PM
Gerberding Julie L.EVP Strat Comm, GI Pub PolicyJul 17Sale80.0036,2852,902,97626,577Jul 20 04:53 PM
BRUN LESLIE ADirectorMay 07Option Exercise0.005,00006,948May 07 04:48 PM
WEEKS WENDELL PDirectorMay 07Option Exercise0.005,00005,100May 07 04:50 PM
BRUN LESLIE ADirectorMay 07Sale75.465,000377,3001,948May 07 04:48 PM
WEEKS WENDELL PDirectorMay 07Sale76.025,000380,104100May 07 04:50 PM
Nally MichaelEVP, Chief Marketing OfficerMay 05Option Exercise76.862,345180,23712,054May 06 05:14 PM
Karachun Rita ASr. VP Fince-Global ControllerMay 05Option Exercise76.863,283252,33129,401May 06 05:15 PM
Fleming MichaelSVP Chief Ethics & Com OfficerMay 05Option Exercise76.861,29099,1497,304May 06 05:16 PM
Clyburn FrankEVP, Chief Commercial OfficerMay 05Option Exercise76.863,752288,37982,611May 06 05:17 PM
Clyburn FrankEVP, Chief Commercial OfficerMay 04Option Exercise77.671,904147,88479,797May 06 05:17 PM
Fleming MichaelSVP Chief Ethics & Com OfficerMay 04Option Exercise77.6769253,7486,252May 06 05:16 PM
Karachun Rita ASr. VP Fince-Global ControllerMay 04Option Exercise77.671,21294,13626,715May 06 05:15 PM
Zachary JenniferEVP, General CounselMay 04Option Exercise77.675,772448,3119,489May 06 05:13 PM
Nally MichaelEVP, Chief Marketing OfficerMay 04Option Exercise77.671,298100,81610,274May 06 05:14 PM
Karachun Rita ASr. VP Fince-Global ControllerMay 03Option Exercise77.6787567,96125,934May 05 04:48 PM
Fleming MichaelSVP Chief Ethics & Com OfficerMay 03Option Exercise77.671,541119,6896,089May 05 04:42 PM
Gerberding Julie L.EVP Strat Comm, GI Pub PolicyJan 13Option Exercise0.0082,5480139,111Jan 15 05:15 PM
Gerberding Julie L.EVP Strat Comm, GI Pub PolicyJan 13Sale89.34102,0739,118,86537,038Jan 15 05:15 PM
Nally MichaelEVP, Chief Marketing OfficerOct 30Option Exercise0.002,28706,196Nov 01 05:07 PM
MIZELL STEVENEVP, Chief HR OfficerOct 30Option Exercise0.004,57404,574Nov 01 05:07 PM
Clyburn FrankEVP, Chief Commercial OfficerOct 30Option Exercise0.002,287073,032Nov 01 05:06 PM
Scholefield James HEVP,Chief Info&Digital OfficerOct 30Option Exercise0.0011,436011,436Nov 01 05:04 PM
DeLuca Richard R.EVP&Pres, Merck Animal HeallthAug 09Option Exercise0.006,427077,951Aug 12 05:13 PM
DeLuca Richard R.EVP&Pres, Merck Animal HeallthAug 09Sale85.096,427546,85071,524Aug 12 05:13 PM